sentences:  A program of the Innovative Medicine Initiative (IMI) that partners pharmaceutical companies with academic institutions and biotech organizations in an effort to solve the scientific, regulatory and business challenges posed by antibiotic resistance.The company directs its oncology research towards development of antitumor drugs that overcome drug-resistance problems associated with currently available cancer treatment drugs for both hematological and solid cancers.Its products include